Jhpiego Wins USAID Grand Challenges Design Competition for Ebola

Nisa PatelArticle, News

In December 2014, Jhpiego, in partnership with Johns Hopkins University’s Center for Bioengineering Innovation and Design (CBID), placed first in USAID’s Grand Challenges for Ebola competition for their innovations to the Ebola protective suit. GBCHealth spoke to Dr. Chandrakant Ruparelia, Senior Technical Advisor of Jhpiego, about the winning submission and how the organization is working to prevent and control Ebola … Read More

Nisa PatelJhpiego Wins USAID Grand Challenges Design Competition for Ebola

New Private Sector Opportunities Approved, Governance Reforms Launched at Global Fund 32nd Board Meeting

Nisa PatelArticle, Newsletter

November 18 – 21, 2014 | Montreux, Switzerland The Global Fund Board met for its 32nd Board meeting in Montreux, Switzerland from November 18-21.  Over the course of the meetings, the Board approved major decisions including: amendments allowing the private sector to make restricted financial contributions against unfunded portions of approved country grant requests reforms to enhance Board and committee … Read More

Nisa PatelNew Private Sector Opportunities Approved, Governance Reforms Launched at Global Fund 32nd Board Meeting

2014 Business Action on Health Awards (Commended): Cycle Technologies

Nisa PatelArticle, News

COMMENDED: Cycle Technologies Program: Solutions for Unmet Need in Family Planning About the Community Investment Program: Since 2002, Cycle Technologies has partnered with the Institute for Reproductive Health (IRH) at Georgetown University under the Solutions for Unmet Need in Family Planning (SUN-FP) program to provide family planning options that meet the needs of women who are at risk for unplanned pregnancies. Under SUN-FP, Cycle … Read More

Nisa Patel2014 Business Action on Health Awards (Commended): Cycle Technologies

The Latest 2014 Maternal, Newborn and Child Health Reports

Margaret ArbogastArticle

As we near the final year marker for the Millennium Development Goals, The Partnership for Maternal, Newborn and Child Health, Countdown to 2015: Maternal, Newborn and Child Survival, and the Independent Expert Review Group have released reports on the current progress of health programming to reduce the burden of death and disease, the gaps in programming, financing and infrastructure, and … Read More

Margaret ArbogastThe Latest 2014 Maternal, Newborn and Child Health Reports

The Global Fund’s Innovation Coalition: Turning Challenges into Opportunities

Nisa PatelArticle

The Global Fund to Fight AIDS, Tuberculosis and Malaria recently launched the Innovation Coalition, a global, multi-sector partnership platform designed to draw on the innovations, creative energy and solution-oriented approaches of private sector companies, academia and civil society to help solve some of the recurring challenges encountered by Global Fund grant recipients. The Innovation Coalition will identify high-impact opportunities to … Read More

Nisa PatelThe Global Fund’s Innovation Coalition: Turning Challenges into Opportunities

Eli Lilly: Searching for New Tuberculosis Drugs

Nisa PatelArticle

Most TB drugs currently approved for treatment are 50+ years old and are required to be taken over a 6-month period to be effective. Compliance with such a long treatment regimen is a challenge, limiting drugs’ effectiveness and contributing to the rise in MDR-TB. As part of its MDR-TB Partnership, Eli Lilly and Company formed innovative partnerships with the Infectious … Read More

Nisa PatelEli Lilly: Searching for New Tuberculosis Drugs

Meet the PSD: Erika Satterwhite & René Cazetien

Nisa PatelArticle

Erika Satterwhite Manager, Global Policy, Mylan René Cazetien Associate Vice President of Operations, Access to Medicines, Sanofi How did Mylan become involved with the Global Fund? Mylan’s decision to join the PSD Advisory Group is rooted in the company’s desire to provide the often-missing generic manufacturer’s perspective in shaping good public policy around the Global Fund’s efforts to combat HIV/AIDS, TB, … Read More

Nisa PatelMeet the PSD: Erika Satterwhite & René Cazetien

Must Read: Articles from World Malaria Day

Nisa PatelArticle

The global malaria community observed World Malaria Day on April 25th. This year’s theme, “Invest in the Future: Defeat Malaria,” focused attention on the impact of the disease and its implications for the post-2015 development agenda. The world has moved closer to achieving malaria elimination: since 2000, malaria-related deaths have reduced by 42% globally and 49% in Africa, resulting in … Read More

Nisa PatelMust Read: Articles from World Malaria Day

PSC Perspectives: The Burgeoning Problem of Insecticide Resistance

Nisa PatelArticle

By Egon Weinmueller, Head of Business Management Global Public Health, BASF Vector control measures have helped reduce malaria-related sickness and death worldwide.  However, mosquito resistance to insecticides presents a growing challenge. Two thirds of countries with ongoing malaria transmission now report insecticide resistance and without proper intervention[1] the problem could lead to a dramatic and devastating resurgence. Growing metabolic resistance … Read More

Nisa PatelPSC Perspectives: The Burgeoning Problem of Insecticide Resistance

Frequently Asked Questions: GBCHealth Changes and Future Direction

hcoulsonArticle

Q.   We’re budgeting for 2014 now.  I know we won’t be invoiced for membership dues. Should we earmark funds for GBCHealth? A.   We welcome continued engagement and support from members. If you are interested in discussing opportunities with GBCHealth, please contact your relationship manager or Executive Director Michael Schreiber at mschreiber@gbchealth.org. We will continue to be registered in the United States … Read More

hcoulsonFrequently Asked Questions: GBCHealth Changes and Future Direction